세계의 수의학 감염성 질환 진단 시장 보고서(2025년)
Veterinary Infectious Disease Diagnostics Global Market Report 2025
상품코드 : 1793360
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수의학 감염성 질환 진단 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 9.7%를 나타내 30억 5,000만 달러로 성장할 전망입니다. 예측기간의 성장은 신흥질환, 연구개발 증가, 수의사 진료의 세계화, 가축두수 증가에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 기술 혁신, 포인트 오브 케어검사의 급속한 보급, 분자진단학의 통합, 동물용 헬스케어에서의 디지털화, 제품 포트폴리오의 확대, 공동 연구와 파트너십, 동물종별 커스터마이즈 진단 등을 들 수 있습니다.

향후 5년간의 성장률 9.7%라고 하는 예측은 전회의 예측으로부터 0.1%의 미감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세로 인한 신속한 측정 키트 및 시약의 혼란은 동물 집단에서 감염 발생에 대한 신속한 대응을 방해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

광견병과 같은 월경감염과 인수공통감염증의 발생률 상승이 향후 수의학 감염성 질환 진단 시장 성장을 견인할 것으로 예측됩니다. 인간 짐승 공통 감염은 인간과 척추 동물 사이에서 자연적으로 감염되는 감염입니다. 수의학 감염성 질환 진단은 반려동물과 동물의 광견병을 감지하고 치명적인 결과를 예방하는 데 중요한 역할을합니다. 예를 들어 2022년 스위스에 본부를 두고 있는 정부기관인 세계보건기구(WHO)는 광견병이 150개 이상의 국가와 지역에 존재한다고 보고했습니다. 개는 인간의 광견병에 의한 사망의 1차 출처이며, 전광견병 감염의 거의 99%를 차지합니다. 또한 광견병이 의심되는 동물에 물린 사람의 40%는 15세 미만의 어린이입니다. 광견병 감염으로 인해 주로 아시아와 아프리카에서 매년 수만 명이 사망합니다. 그러므로 국경을 넘어서는 인물 공통 감염의 유행이 증가하고 있는 것이 수의학 감염성 질환 진단 시장 성장을 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Veterinary infectious disease diagnostics refer to diagnostic services used for the identification of infectious diseases in animals, encompassing infectious diseases and factors impacting the health of livestock, domestic animals, and wildlife. These diagnostics have become essential for ensuring the overall well-being of animals by diagnosing infections in various animal types.

The primary types of veterinary infectious disease diagnostics include viral infections, bacterial infections, parasitic infections, and other infections. Bacterial infections can be transmitted from dogs to humans through dog bites, while other infections caused by protozoa typically have a fecal-oral transmission route. Different animals, such as companion animals and food-producing animals, are covered by these diagnostics, utilizing various technologies like immunodiagnostics, molecular diagnostics, and other diagnostic methods. These diagnostic services are utilized across different settings, including reference laboratories, veterinary hospitals and clinics, point of care facilities, research institutes and universities, and other end-user environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary infectious disease diagnostics market research report is one of a series of new reports from The Business Research Company that provides veterinary infectious disease diagnostics market statistics, including veterinary infectious disease diagnostics industry global market size, regional shares, competitors with a veterinary infectious disease diagnostics market share, detailed veterinary infectious disease diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary infectious disease diagnostics industry. This veterinary infectious disease diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary infectious disease diagnostics market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing pet ownership, advancements in veterinary medicine, humanization of pets, regulatory support.

The veterinary infectious disease diagnostics market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emerging diseases, increased research and development, globalization of veterinary practices, and growing livestock population. Major trends in the forecast period include technological innovations, rapid adoption of point-of-care testing, integration of molecular diagnostics, digitalization in veterinary healthcare, expansion of product portfolios, collaborations and partnerships, customized diagnostics for different animal species.

The forecast of 9.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff-induced disruptions to rapid assay kits and reagents may impede fast response to infectious disease outbreaks in animal populations. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of transboundary and zoonotic diseases, such as rabies, is expected to drive the growth of the veterinary infectious disease diagnostics market in the future. Zoonoses are infections and diseases that are transmitted spontaneously between humans and vertebrate animals. Veterinary infectious disease diagnostics play a crucial role in detecting rabies in pets and animals, helping to prevent fatal outcomes. For example, in 2022, the World Health Organization (WHO), a Swiss-based government agency, reported that rabies was present in over 150 countries and territories. Dogs are the primary source of human rabies fatalities, accounting for nearly 99% of all rabies transmissions. Additionally, children under 15 years old represent 40% of those bitten by suspected rabid animals. Rabies infection results in tens of thousands of deaths each year, primarily in Asia and Africa. Therefore, the increasing prevalence of transboundary and zoonotic diseases is propelling the growth of the veterinary infectious disease diagnostics market.

The increasing rate of pet adoption is anticipated to drive the growth of the veterinary infectious disease diagnostics market in the coming years. There is a high demand for animal treatments and diagnostics as more individuals welcome pets into their families and become increasingly aware of and concerned about their health. Pet owners are willing to invest in medical care, regular check-ups, and preventive measures. For instance, in 2023, Shelter Animals Count, a US-based non-governmental organization, reported that dog adoptions rose by 109,000 compared to 2022, reflecting a positive trend in adoption rates. However, the total number of dogs adopted in 2023 is still approximately 108,000 lower than the previous year. Thus, the rising rate of pet adoption is fueling the veterinary infectious disease diagnostics market during the forecast period.

Technological advancements have emerged as a prominent trend in the veterinary infectious disease diagnostics market, with major companies introducing innovative technologies to maintain their market positions. For example, Merck Animal Health launched SenseHub Feedlot, a technology-enabled solution based on electronic ear tag technology. This system swiftly detects illness, provides reliable disease diagnoses, and allows for early intervention to manage pain in cattle more effectively than traditional methods.

Major companies operating in the veterinary infectious disease diagnostics market are also intensifying their focus on developing and introducing drugs for multiple diseases. One such example is the drug Increxxa, approved for treating livestock respiratory disease. Elanco Animal Health Incorporated introduced Increxxa, featuring tulathromycin as the key ingredient, delivered via injection to swiftly target and act on lung infections in livestock. Tulathromycin helps mitigate the negative effects of bovine respiratory disease in animals. This strategic focus on drug development is aimed at gaining a competitive edge in the veterinary infectious disease diagnostics market.

In September 2022, Zoetis Inc., a prominent animal health company, acquired NewMetrica for an undisclosed amount. This acquisition enhances Zoetis's portfolio in pain management for animal diseases, strengthens quality-of-life assessment capabilities, and extends the reach of their animal diagnostic products to Europe. NewMetrica, a UK-based company, specializes in developing instruments and devices for pain management in animals.

Major companies operating in the veterinary infectious disease diagnostics market include Zoetis Inc., IDEXX Laboratories Inc., Thermo Fisher Scientific Inc., QIAGEN N. V., IDvet, NEOGEN Corporation, INDICAL BIOSCIENCE GmbH, Randox Laboratories Ltd, Creative Diagnostics, Heska Corporation, Chembio Diagnostics Inc., URIT Medical Electronic Co. Ltd., NTBIO Diagnostics Inc., Bio-X Diagnostics, Agrolabo Spa, Virbac, Covetrus Inc., Biomerieux S. A., Bio-Rad Laboratories Inc., Eurofins Scientific SE, Fujifilm Wako Pure Chemical Corporation, GenScript Biotech Corporation, Merck KGaA, MP Biomedicals LLC, Quidel Corporation, Roche Diagnostics Corporation, Siemens Healthineers AG, Sysmex Corporation, VCA Inc., Vetoquinol SA

North America was the largest region in the veterinary disease diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary infectious disease diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the veterinary infectious disease diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The veterinary infectious disease diagnostics market includes revenues earned by entities by identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Infectious Disease Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary infectious disease diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary infectious disease diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary infectious disease diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Infectious Disease Diagnostics Market Characteristics

3. Veterinary Infectious Disease Diagnostics Market Trends And Strategies

4. Veterinary Infectious Disease Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Veterinary Infectious Disease Diagnostics Growth Analysis And Strategic Analysis Framework

6. Veterinary Infectious Disease Diagnostics Market Segmentation

7. Veterinary Infectious Disease Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Veterinary Infectious Disease Diagnostics Market

9. China Veterinary Infectious Disease Diagnostics Market

10. India Veterinary Infectious Disease Diagnostics Market

11. Japan Veterinary Infectious Disease Diagnostics Market

12. Australia Veterinary Infectious Disease Diagnostics Market

13. Indonesia Veterinary Infectious Disease Diagnostics Market

14. South Korea Veterinary Infectious Disease Diagnostics Market

15. Western Europe Veterinary Infectious Disease Diagnostics Market

16. UK Veterinary Infectious Disease Diagnostics Market

17. Germany Veterinary Infectious Disease Diagnostics Market

18. France Veterinary Infectious Disease Diagnostics Market

19. Italy Veterinary Infectious Disease Diagnostics Market

20. Spain Veterinary Infectious Disease Diagnostics Market

21. Eastern Europe Veterinary Infectious Disease Diagnostics Market

22. Russia Veterinary Infectious Disease Diagnostics Market

23. North America Veterinary Infectious Disease Diagnostics Market

24. USA Veterinary Infectious Disease Diagnostics Market

25. Canada Veterinary Infectious Disease Diagnostics Market

26. South America Veterinary Infectious Disease Diagnostics Market

27. Brazil Veterinary Infectious Disease Diagnostics Market

28. Middle East Veterinary Infectious Disease Diagnostics Market

29. Africa Veterinary Infectious Disease Diagnostics Market

30. Veterinary Infectious Disease Diagnostics Market Competitive Landscape And Company Profiles

31. Veterinary Infectious Disease Diagnostics Market Other Major And Innovative Companies

32. Global Veterinary Infectious Disease Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Infectious Disease Diagnostics Market

34. Recent Developments In The Veterinary Infectious Disease Diagnostics Market

35. Veterinary Infectious Disease Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기